Potential Co-Factor Role of Tobacco Specific Nitrosamine Exposures in the Pathogenesis of Fetal Alcohol Spectrum Disorder
DOI:
https://doi.org/10.17140/GOROJ-2-125Keywords:
Insulin resistance, Fetal alcohol spectrum disorder, Tobacco, Cerebellum, NNK, NitrosamineAbstract
Background: Cerebellar developmental abnormalities in Fetal Alcohol Spectrum Disorder (FASD) are linked to impairments in insulin signaling. However, co-morbid alcohol and tobacco abuses during pregnancy are common. Since smoking leads to tobacco specific Nitrosamine (NNK) exposures which have been shown to cause brain insulin resistance, we hypothesized that neurodevelopmental abnormalities in FASD could be mediated by ethanol and/or NNK.
Methods: Long Evans rat pups were intraperitoneal (IP) administered ethanol (2 g/kg) on postnatal days (P) 2, 4, 6 and/or NNK (2 mg/kg) on P3, P5, and P7 to simulate third trimester human exposures. The Cerebellar function, histology, insulin and Insulin-like Growth Factor (IGF) signaling, and neuroglial protein expression were assessed.
Results: Ethanol, NNK and ethanol+NNK groups had significant impairments in motor function (rotarod tests), abnormalities in cerebellar structure (Purkinje cell loss, simplification and irregularity of folia, and altered white matter), signaling through the insulin and IGF-1 receptors, IRS-1, Akt and GSK-3β, and reduced expression of several important neuroglial proteins. Despite similar functional effects, the mechanisms and severity of NNK and ethanol+NNK induced alterations in cerebellar protein expression differed from those of ethanol.
Conclusions: Ethanol and NNK exert independent but overlapping adverse effects on cerebellar development, function, insulin signaling through cell survival, plasticity, metabolic pathways, and neuroglial protein expression. The results support the hypothesis that tobacco smoke exposure can serve as a co-factor mediating long-term effects on brain structure and function in FASD.
References
Mattson SN, Crocker N, Nguyen TT. Fetal alcohol spectrum disorders: neuropsychological and behavioral features. Neuro-psychol Rev. 2011;21(2): 81-101. doi: 10.1007/s11065-011- 9167-9
Riley EP, Infante MA, Warren KR. Fetal alcohol spectrum disorders: an overview. Neuropsychol Rev. 2011; 21(2): 73-80. doi: 10.1007/s11065-011-9166-x
de la Monte SM, Wands JR. Role of central nervous system insulin resistance in fetal alcohol spectrum disorders. J Popul Ther Clin Pharmacol. 2010; 17(3): e390-e404.
Banerjee K, Mohr L, Wands JR, de la Monte SM. Ethanol inhibition of insulin signaling in hepatocellular carcinoma cells. Alcohol Clin Exp Res. 1998; 22(9): 2093-2101. doi: 10.1111/ j.1530-0277.1998.tb05921.x
Mohr L, Tanaka S, Wands JR. Ethanol inhibits hepatocyte proliferation in insulin receptor substrate 1 transgenic mice. Gastroenterology. 1998; 115(6): 1558-1565.
Xu J, Yeon JE, Chang H, et al. Ethanol impairs insulin-stim-ulated neuronal survival in the developing brain: role of PTEN phosphatase. J Biol Chem. 2003; 278(29): 26929-26937. doi: 10.1074/jbc.M300401200
Soscia SJ, Tong M, Xu XJ, et al. Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetyl-choline homeostasis in the brain. Cell Mol Life Sci. 2006; 63(17): 2039-2056.
He J, de la Monte S, Wands JR. Acute ethanol exposure inhib-its insulin signaling in the liver. Hepatology. 2007; 46(6): 1791- 1800. doi: 10.1002/hep.21904
Yeon JE, Califano S, Xu J, Wands JR, De La Monte SM. Po-tential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver. Hepatology. 2003; 38(3): 703-714. doi:
1053/jhep.2003.50368 10. Camp MC, Mayfield RD, McCracken M, McCracken L, Alcantara AA. Neuroadaptations of Cdk5 in cholinergic in-terneurons of the nucleus accumbens and prefrontal cortex of inbred alcohol-preferring rats following voluntary alcohol drinking. Alcohol Clin Exp Res. 2006; 30(8): 1322-1335. doi: 10.1111/j.1530-0277.2006.00160.x
de la Monte SM, Ganju N, Banerjee K, Brown NV, Luong T, Wands JR. Partial rescue of ethanol-induced neuronal apoptosis by growth factor activation of phosphoinositol-3-kinase. Alco-hol Clin Exp Res. 2000; 24(5): 716-726. doi: 10.1111/j.1530- 0277.2000.tb02044.x
de la Monte SM, Neely TR, Cannon J, Wands JR. Ethanol impairs insulin- stimulated mitochondrial function in cerebellar granule neurons. Cell Mol Life Sci. 2001; 58(12-13): 1950-1960.
Hallak H, Seiler AE, Green JS, Henderson A, Ross BN, Rubin R. Inhibition of insulin-like growth factor-I signaling by ethanol in neuronal cells. Alcohol Clin Exp Res. 2001; 25(7): 1058-1064. doi: 10.1111/j.1530-0277.2001.tb02317.x
Rajgopal Y, Vemuri MC. Ethanol induced changes in cyclin-dependent kinase-5 activity and its activators, P35, P67 (Munc-18) in rat brain. Neurosci Lett. 2001; 308(3): 173-176. doi: 10.1016/S0304-3940(01)02011-0
Zhang FX, Rubin R, Rooney TA. Ethanol induces apoptosis in cerebellar granule neurons by inhibiting insulin-like growth factor 1 signaling. J Neurochem. 1998; 71(1): 196-204. doi: 10.1046/j.1471-4159.1998.71010196.x
Kuriyama K, Ohkuma S, Taguchi J, Hashimoto T. Alcohol, acetaldehyde and salsolinol-induced alterations in functions of cerebral GABA/benzodiazepine receptor complex. Physiol Be-hav. 1987; 40(3): 393-399.
Smith RA, Orr DJ, Haetzman ML, MacPherson N, Storey ND. The response of primary cultured adult mouse sensory neu-rons to ethanol, propanol, acetaldehyde and acrolein treatments. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990; 58(5): 323- 330.
Rintala J, Jaatinen P, Parkkila S, et al. Evidence of acetal-dehyde-protein adduct formation in rat brain after lifelong con-sumption of ethanol. Alcohol Alcohol. 2000; 35(5): 458-463. doi: 10.1093/alcalc/35.5.458
Upadhya SC, Ravindranath V. Detection and localization of protein-acetaldehyde adducts in rat brain after chronic etha-nol treatment. Alcohol Clin Exp Res. 2002; 26(6): 856-863. doi: 10.1111/j.1530-0277.2002.tb02615.x
Lamarche F, Gonthier B, Signorini N, Eysseric H, Barret L. Impact of ethanol and acetaldehyde on DNA and cell viability of cultured neurones. Cell Biol Toxicol. 2004; 20(6): 361-374.
Haorah J, Ramirez SH, Floreani N, Gorantla S, Morsey B, Persidsky Y. Mechanism of alcohol-induced oxidative stress and neuronal injury. Free Radic Biol Med. 2008; 45(11): 1542-1550. doi: 10.1016/j.freeradbiomed.2008.08.030
Romberger DJ, Grant K. Alcohol consumption and smoking status: the role of smoking cessation. Biomedicine & pharmaco-therapy. 2004; 58(2): 77-83. doi: 10.1016/j.biopha.2003.12.002
Durazzo TC, Rothlind JC, Cardenas VA, Studholme C, Weiner MW, Meyerhoff DJ. Chronic cigarette smoking and heavy drinking in human immunodeficiency virus: consequences for neurocognition and brain morphology. Alcohol. 2007; 41(7): 489-501. doi: 10.1016/j.alcohol.2007.07.007
Tai M, Piskorski A, Kao JCW, Hess LA, de la Monte SM, Gundogan F. Gestational alcohol effects on placental morphol-ogy. Pediatr Dev Pathol. 2014; 17(2): 146.
Jacobsen LK, Slotkin TA, Mencl WE, Frost SJ, Pugh KR. Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. Neuropsy-chopharmacology. 2007; 32(12): 2453-2464. doi: 10.1038/ sj.npp.1301398
Duell EJ. Epidemiology and potential mechanisms of tobac-co smoking and heavy alcohol consumption in pancreatic cancer. Mol Carcinog. 2012; 51(1): 40-52. doi: 10.1002/mc.20786
Go VL, Gukovskaya A, Pandol SJ. Alcohol and pancreatic cancer. Alcohol. 2005; 35(3): 205-211.
Lao Y, Yu N, Kassie F, Villalta PW, Hecht SS. Forma-tion and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanol. Chem Res Toxicol. 2007; 20(2): 235-245. doi: 10.1021/tx060207r
Upadhyaya P, Lindgren BR, Hecht SS. Comparative levels of O6-methylguanine, pyridyloxobutyl-, and pyridylhydroxybu-tyl-DNAadducts in lung and liver of rats treated chronically with the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1- butanone. Drug Metab Dispos. 2009; 37(6): 1147- 1151. doi: 10.1124/dmd.109.027078
Zabala V, Tong M, Yu R, et al. Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease. Alcohol Alcohol. 2015; 50(2): 118-31. doi: 10.1093/alcalc/agu083
Tong M, Longato L, de la Monte SM. Early limited nitrosa-mine exposures exacerbate high fat diet-mediated type 2 diabe-tes and neurodegeneration. BMC Endocr Disord. 2010; 10(1): 4. doi: 10.1186/1472-6823-10-4
Tong M, Yu R, Deochand C, de la Monte SM. Differential Contributions of Alcohol and the Nicotine-Derived Nitrosamine Ketone (NNK) to Insulin and Insulin-Like Growth Factor Re-sistance in the Adolescent Rat Brain. Alcohol Alcohol. 2015; 50(6): 670-679. doi: 1093/alcalc/agv101
Tong M, Yu R, Silbermann E, Zabala V, Deochand C, de la Monte SM. Differential Contributions of Alcohol and Nicotine-Derived Nitrosamine Ketone (NNK) to White Matter Pathol-ogy in the Adolescent Rat Brain. Alcohol Alcohol. 2015; 50(6): 680-689. doi: 10.1093/alcalc/agv102
Andreani T, Tong M, de la Monte SM. Hotdogs and Beer: Dietary Nitrosamine Exposure Exacerbates Neurodevelopmen-tal Effects of Ethanol in Fetal Alcohol Spectrum Disorder. JDAR. 2014; 3(2014): 1-9. doi: 10.4303/jdar/235811
Li Z, Zharikova A, Vaughan CH, et al. Intermittent high-dose ethanol exposures increase motivation for operant ethanol self- administration: possible neurochemical mechanism. Brain Res. 2010; 1310: 142-153. doi: 10.1016/j.brainres.2009.11.029
Silvers JM, Tokunaga S, Mittleman G, O’Buckley T, Mor-row AL, Matthews DB. Chronic intermittent ethanol exposure during adolescence reduces the effect of ethanol challenge on hippocampal allopregnanolone levels and Morris water maze task performance. Alcohol. 2006; 39(3): 151-158. doi: 10.1016/j. alcohol.2006.09.001
de Licona HK, Karacay B, Mahoney J, McDonald E, Luang T, Bonthius DJ. A single exposure to alcohol during brain devel-opment induces microencephaly and neuronal losses in geneti-cally susceptible mice, but not in wild type mice. Neurotoxicol-ogy. 2009; 30(3): 459-470. doi: 10.1016/j.neuro.2009.01.010
Hamm RJ, Pike BR, O’Dell DM, Lyeth BG, Jenkins LW. The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma. 1994; 11(2): 187-196.
Longato L, Ripp K, Setshedi M, et al. Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in hu-man chronic alcohol-related liver disease. Oxid Med Cell Lon-gev. 2012; 2012: 479348. doi: 10.1155/2012/479348
de la Monte SM, Tong M, Carlson RI, et al. Ethanol inhi-bition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: Potential link to the impairments in central nervous system neuronal migration. Alcohol. 2009; 43(3): 225- 240. doi: 10.1016/j.alcohol.2008.09.009
Bernert JT, Gordon SM, Jain RB, et al. Increases in tobacco exposure biomarkers measured in non-smokers exposed to side-stream cigarette smoke under controlled conditions. Biomarkers. 2009; 14(2): 82-93. doi: 10.1080/13547500902774613
Thomas JL, Guo H, Carmella SG, et al. Metabolites of a tobacco-specific lung carcinogen in children exposed to sec-ondhand or thirdh and tobacco smoke in their homes. Cancer Epidemiol Biomarkers Prev. 2011; 20(6): 1213-1221. doi: 10.1158/1055-9965.EPI-10-1027
Karacay B, Li S, Bonthius DJ. Maturation-dependent alco-hol resistance in the developing mouse: cerebellar neuronal loss and gene expression during alcohol- vulnerable and -resistant periods. Alcohol Clin Exp Res. 2008; 32(8): 1439-1450. doi: 10.1111/j.1530-0277.2008.00720.x
de la Monte SM, Wands JR. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer’s disease. J Al-zheimers Dis. 2005; 7(1): 45-61.
Draznin B. Molecular mechanisms of insulin resistance: ser-ine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes. 2006; 55(8): 2392-2397. doi: 10.2337/db06-0391
de la Monte SM, Wands JR. Chronic gestational exposure to ethanol impairs insulin-stimulated survival and mitochondrial function in cerebellar neurons. Cell Mol Life Sci. 2002; 59: 882- 893.
Carter JJ, Tong M, Silbermann E, et al. Ethanol impaired neuronal migration is associated with reduced aspartyl-aspa-raginyl- beta-hydroxylase expression. Acta Neuropathol. 2008; 116(3): 303-315. doi: 10.1007/s00401-008-0377-z
Deochand C, Tong M, Agarwal AR, Cadenas E, de la Monte SM. Tobacco Smoke Exposure Impairs Brain Insulin/IGF Sig-naling: Potential Co-Factor Role in Neurodegeneration. J Al-zheimers Dis. 2015; 50(2): 373-386. doi: 10.3233/JAD-150664
de la Monte SM. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease. Curr Alzheimer Res. 2012; 9(1): 35-66. doi: 10.2174/156720512799015037
Hong M, Lee VM. Insulin and insulin-like growth fac-tor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem. 1997; 272(31): 19547-19553. doi: 10.1074/ jbc.272.31.19547
Schubert M, Gautam D, Surjo D, et al. Role for neuronal insu-lin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A. 2004; 101(9): 3100-3105. doi: 10.1073/pnas.0308724101
dos Santos AA, dos Santos DB, Ribeiro RP, et al. Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice. Neurotoxicology. 2011; 32(6): 888-895. doi: 10.1016/j.neuro.2011.05.008
Ehrich M, Van Tassell R, Li Y, Zhou Z, Kepley CL. Fuller-ene antioxidants decrease organophosphate-induced acetylcho-linesterase inhibition in vitro. Toxicol In Vitro. 2011; 25(1): 301- 307. doi: 10.1016/j.tiv.2010.09.010
Kazi AI, Oommen A. Monocrotophos induced oxidative damage associates with severe acetylcholinesterase inhibition in rat brain. Neurotoxicology. 2012; 33(2): 156-161. doi: 10.1016/j. neuro.2012.01.008
Ansari MA, Abdul HM, Joshi G, Opii WO, Butterfield DA. Protective effect of quercetin in primary neurons against Abe-ta(1-42): relevance to Alzheimer’s disease. J Nutr Biochem. 2009; 20(4): 269-275.
Bardag-Gorce F. Effects of ethanol on the proteasome in-teracting proteins. World J Gastroenterol. 2010; 16(11): 1349- 1357. doi: 10.3748/wjg.v16.i11.1349
French SW. Mechanisms of alcoholic liver injury. Can J Gastroenterol. 2000; 14(4): 327-332.
Ying Z, Wang H, Wang G. The ubiquitin proteasome sys-tem as a potential target for the treatment of neurodegenera-tive diseases. Curr Pharm Des. 2013; 19(18): 3305-3314. doi: 10.2174/1381612811319180013
Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, Scheper W. The unfolded protein response is activated in pretangle neurons in Alzheimer’s disease hippocam-pus. Am J Pathol. 2009; 174(4): 1241-1251.
de la Monte SM. Triangulated mal-signaling in Alzheimer’s disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed. J Alzheimers Dis. 2012; 30 Supp 2: S231- S249. doi: 10.3233/JAD-2012-111727
de la Monte SM, Re E, Longato L, Tong M. Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer’s disease. J Alzheimers Dis. 2012; 30 Supp 2: S217-S229. doi: 10.3233/JAD-2012-111728
Lahousse SA, Carter JJ, Xu XJ, Wands JR, de la Monte SM. Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblas-toma cells. BMC cell biology. 2006; 7: 41. doi: 10.1186/1471- 2121-7-41
Lawton M, Tong M, Gundogan F, Wands JR, de la Monte SM. Aspartyl- (asparaginyl) beta-hydroxylase, hypoxia-induc-ible factor-alpha and Notch cross-talk in regulating neuronal mo-tility. Oxid Med Cell Longev. 2010; 3(5): 347-356. doi: 10.4161/ oxim.3.5.13296
Longato L, de la Monte S, Kuzushita N, et al. Overexpres-sion of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver. Hepatology. 2009; 49(6): 1935-1943.
Maeda T, Sepe P, Lahousse S, et al. Antisense oligodeoxy-nucleotides directed against aspartyl (asparaginyl) beta-hydrox-ylase suppress migration of cholangiocarcinoma cells. J Hepatol. 2003; 38(5): 615-622. doi: 10.1016/S0168-8278(03)00052-7
Ince N, de la Monte SM, Wands JR. Overexpression of hu-man aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation. Cancer Res. 2000; 60(5): 1261-1266.
Cantarini MC, de la Monte SM, Pang M, et al. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology. 2006; 44(2): 446-457. doi: 10.1002/hep.21272
de la Monte SM, Tamaki S, Cantarini MC, et al. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcino-ma invasiveness. JHepatol. 2006; 44(5): 971-983. doi: 10.1016/j. jhep.2006.01.038
Sepe PS, Lahousse SA, Gemelli B, et al. Role of the as-partyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility. Lab Invest. 2002; 82(7): 881-891.
Silbermann E, Moskal P, Bowling N, Tong M, de la Monte SM. Role of aspartyl- (asparaginyl)-beta-hydroxylase mediated notch signaling in cerebellar development and function. Behav Brain Funct. 2010; 6: 68. doi: 10.1186/1744-9081-6-68
Feriotto G, Finotti A, Breveglieri G, Treves S, Zorzato F, Gambari R. Transcriptional activity and Sp 1/3 transcription fac-tor binding to the P1 promoter sequences of the human AbetaH-J-J locus. FEBS J. 2007; 274(17): 4476-4490.
Gundogan F, Bedoya A, Gilligan J, Lau E, Mark P, De Paepe ME, et al. siRNA inhibition of aspartyl-asparaginyl beta-hydroxylase expression impairs cell motility, Notch signaling, and fetal growth. Pathol Res Pract. 2011; 207(9): 545-553.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Gynecology and Obstetrics Research (GOR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
